The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
5 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,816,716 in first-year total cost, median $252,121.
Most frequent study sections
- Special Emphasis Panel[ZES1 LWJ-S (R4)]5
Most frequent institutions
- AMELIA TECHNOLOGIES, LLC1
- BIOSPYDER TECHNOLOGIES, INC.1
- CORAL GENOMICS, INC.1
- NEMALIFE INC.1
- PROPAGENIX, INC.1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2021 | In Vitro Toxicity Testing at Massive Scale in Diverse Primary Human Cells1R44ES032515-01 | DIXIT, ATRAY | CORAL GENOMICS, INC., CA | $811,373 | ZES1 |
| 2021 | A Commercially Durable Biobank of Genetically Diverse and Differentiation Competent Primary Airway Progenitor Cells Validated for In Vitro Toxicology Screening1R43ES032523-01 | POLLOK, BRIAN ANDREW | PROPAGENIX, INC., MD | $252,131 | ZES1 |
| 2021 | TempO-Seq assay and cell panel for assessing impact of genetic diversity on compound bioactivity and toxicity risk1R43ES032514-01 | SELIGMANN, BRUCE E. | BIOSPYDER TECHNOLOGIES, INC., CA | $252,121 | ZES1 |
| 2021 | A novel technology to assess chronic toxicity in genetically diverse nematode populations1R43ES032516-01 | TOTH, MARTON | NEMALIFE INC., TX | $251,040 | ZES1 |
| 2021 | Barcoded human cells engineered with heterozygous genetic diversity to uncover toxicodynamic variability1R44ES032522-01 | GEORGE, JAYSOBOL, ROBERT W | AMELIA TECHNOLOGIES, LLC, DC | $250,051 | ZES1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.